OARSI/OMERACT initiative to define states of severity and indication for joint replacement in hip and knee osteoarthritis. An OMERACT 10 special interest group

Journal of Rheumatology

Volumn 38, Issue 8, 2011, Pages 1765-1769

  Gossec, Laure ^a,b   Paternotte, Simon ^a,b   Bingham III, Clifton O ^c   Clegg, Daniel O ^d   Coste, Philippe ^e   Conaghan, Philip G ^f   Davis, Aileen M ^g   Giacovelli, Giampaolo ^h   Gunther, Klaus Peter ⁱ   Hawker, Gillian ^j,k   Hochberg, Marc C ^l   Jordan, Joanne M ^m   Katz, Jeffrey N ^n,o   Kloppenburg, Margreet ^p   Lanzarotti, Arturo ^q   Lim, Keith ^r   Lohmander, L Stefan ^s   Mahomed, Nizar N ^t   Maillefert, Jean Francis ^u,v,w   Manno, Rebecca L ^c   March, Lyn M ^x   Mazzuca, Steven A ^y   Pavelka, Karel ^z   Punzi, Leonardo ^aa   Roos, Ewa M ^ab   Rovati, Lucio C ^h   Shi, Helen ^ac   Singh, Jasvinder A ^ad   Suarez Almazor, Maria E ^ae   Tajana Messi, Eleonora ^q   Dougados, Maxime ^a,b   more..

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b Johns Hopkins University ^*  (France)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^e Expansciences Laboratories   (France)

^f UNIVERSITY OF LEEDS   (United Kingdom)

^g UNIVERSITY OF TORONTO   (Canada)

^h Rotta Research Laboratorium   (Italy)

ⁱ DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^j WOMEN S COLLEGE HOSPITAL   (Canada)

^k UNIVERSITY OF TORONTO   (Canada)

^l UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^m UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

ⁿ BRIGHAM AND WOMEN S HOSPITAL   (United States)

^o HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^p LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^q IBSA Institut Biochimique SA   (Switzerland)

^r ST VINCENT S HOSPITAL   (Australia)

^s LUND UNIVERSITY   (Sweden)

^t TORONTO WESTERN HOSPITAL   (Canada)

^u DIJON UNIVERSITY HOSPITAL   (France)

^v UNIVERSITÉ DE BOURGOGNE   (France)

^w INSERM   (France)

^x UNIVERSITY OF SYDNEY   (Australia)

^y INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^z CHARLES UNIVERSITY   (Czech Republic)

^aa UNIVERSITY OF PADOVA   (Italy)

^ab UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^ac VA Cooperative Studies Program Coordinating Center   (United States)

^ad UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^ae UNIVERSITY OF TEXAS   (United States)

more..

Author keywords

Function; Osteoarthritis; Pain; Severity; Structure outcome measure

Indexed keywords

CONFERENCE PAPER; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; HEALTH CARE ORGANIZATION; HIP OSTEOARTHRITIS; HIP PAIN; HUMAN; JOINT PROSTHESIS; KNEE OSTEOARTHRITIS; KNEE PAIN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OSTEOARTHRITIS RESEARCH SOCIETY INTERNATIONAL; OUTCOME ASSESSMENT; OUTCOME MEASURES IN RHEUMATOLOGY CLINICAL TRIALS; PAIN ASSESSMENT; PHYSICAL DISEASE; PREVALENCE; PRIORITY JOURNAL; TREATMENT INDICATION; VALIDITY;

ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; HUMANS; INTERNATIONAL COOPERATION; OSTEOARTHRITIS, HIP; OSTEOARTHRITIS, KNEE; OUTCOME ASSESSMENT (HEALTH CARE); PAIN MEASUREMENT; QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 79961125852     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.110403     Document Type: Conference Paper

References (24)

1. Maillefert JF, Hawker GA, Gossec L, Mahomed NN, Lohmander S, Dieppe PA, et al. Concomitant therapy: an outcome variable for musculoskeletal disorders? Part 2: total joint replacement in osteoarthritis trials. J Rheumatol 2005;32:2449-51.
2. Gossec L, Hawker G, Davis AM, Maillefert JF, Lohmander LS, Altman R, et al. OMERACT/OARSI initiative to define states of severity and indication for joint replacement in hip and knee osteoarthritis. J Rheumatol 2007;34:1432-5.
3. Dougados M, Hawker G, Lohmander S, Davis AM, Dieppe P, Maillefert JF, et al. OARSI/OMERACT criteria of being considered a candidate for total joint replacement in knee/hip osteoarthritis as an endpoint in clinical trials evaluating potential disease modifying osteoarthritic drugs. J Rheumatol 2009;36:2097-9.
4. Hawker GA, Davis AM, French MR, Cibere J, Jordan JM, March L, et al. Development and preliminary psychometric testing of a new OA pain measure - an OARSI/OMERACT initiative. Osteoarthritis Cartilage 2008;16:409-14.
5. Maillefert JF, Kloppenburg M, Fernandes L, Punzi L, Günther KP, Martin Mola E, et al. Multi-language translation and cross-cultural adaptation of the OARSI/OMERACT measure of intermittent and constant osteoarthritis pain (ICOAP). Osteoarthritis Cartilage 2009;17:1293-6.
6. Perruccio AV, Lohmander LS, Canizares M, Tennant A, Hawker GA, Conaghan PG, et al. The development of a short measure of physical function for knee OA KOOS-Physical Function Shortform (KOOS-PS) - an OARSI/OMERACT initiative. Osteoarthritis Cartilage 2008;16:542-50.
7. Davis AM, Perruccio AV, Canizares M, Tennant A, Hawker GA, Conaghan PG, et al. The development of a short measure of physical function for hip OA HOOS-Physical Function Shortform (HOOS-PS): an OARSI/OMERACT initiative. Osteoarthritis Cartilage 2008;16:551-9.
8. Davis AM, Perruccio AV, Canizares M, Hawker GA, Roos EM, Maillefert JF, et al. Comparative validity and responsiveness of the HOOS-PS and KOOS-PS to the WOMAC physical function subscale in total joint replacement for osteoarthritis. Osteoarthritis Cartilage 2009;17:843-7.
9. Gossec L, Jordan JM, Lam MA, Fang F, Renner JB, Davis A, et al; for the OARSI-OMERACT task force "total articular replacement as outcome measure in OA." Comparative evaluation of three semi-quantitative radiographic grading techniques for hip osteoarthritis in terms of validity and reproducibility in 1404 radiographs: report of the OARSI-OMERACT Task Force. Osteoarthritis Cartilage 2009;17:182-7.
10. Gossec L, Jordan JM, Mazzuca SA, Lam MA, Suarez-Almazor ME, Renner JB, et al; for the OARSI-OMERACT Task Force "total articular replacement as outcome measure in OA". Comparative evaluation of three semi-quantitative radiographic grading techniques for knee osteoarthritis in terms of validity and reproducibility in 1759 X-rays: report of the OARSI-OMERACT Task Force. Osteoarthritis Cartilage 2008;16:742-8.
11. Ornetti P, Brandt K, Hellio-Le Graverand MP, Hochberg M, Hunter DJ, Kloppenburg M, et al. OARSI-OMERACT definition of relevant radiological progression in hip/knee osteoarthritis. Osteoarthritis Cartilage 2009;17:856-63.
12. Dougados M, Nguyen M, Berdah L, Maziéres B, Vignon E, Lequesne M; ECHODIAH Investigators Study Group. Evaluation of the structure-modifying effects of diacerein in hip osteoarthritis: ECHODIAH, a three-year, placebo-controlled trial. Evaluation of the Chondromodulating Effect of Diacerein in OA of the Hip. Arthritis Rheum 2001;44:2539-47.
13. Maheu E, Cadet C, Marty M, Moyse D, Kerloch I, Coste P, et al; Evaluation of the structure-modifying effect of avocado-soybean unsaponifiables (ASU) in hip osteoarthritis (OA): Results of the ERADIAS Study, a 3-year, prospective, randomized, double-blind, placebo controlled trial [abstract]. Arthritis Rheum 2009;60 Suppl:847.
14. Reginster JY, Deroisy R, Rovati LC, Lee RL, Lejeune E, Bruyere O, et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomized, placebo-controlled clinical trial. Lancet 2001;357:251-6.
15. Pavelka K, Gatterova J, Olejarova M, Machacek S, Giacovelli G, Rovati LC, et al. Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study. Arch Intern Med 2002;162:2113-23.
16. Brandt KD, Mazzuca SA, Katz BP, Lane KA, Buckwalter KA, Yocum DE, et al. Effects of doxycycline on progression of osteoarthritis: results of a randomized, placebo-controlled, double-blind trial. Arthritis Rheum 2005;52:2015-25.
17. Bingham CO 3rd, Buckland-Wright JC, Garnero P, Cohen SB, Dougados M, Adami S, et al. Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthritis structural arthritis study. Arthritis Rheum 2006;54:3494-507.
18. Clegg DO, Reda DJ, Harris CL, Klein MA, O'Dell JR, Hooper MM, et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med 2006;354:795-808.
19. Kahan A, Uebelhart D, de Vathaire F, Delmas PD, Reginster JY. Long-term effects of chondroitins 4 and 6 sulfate on knee osteoarthritis. The study on osteoarthritis progression prevention, a two-year, randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2009;60:524-33.
20. Dieppe P, Judge A, Williams S, Ikwueke I, Guenther KP, Floeren M, et al EUROHIP Study Group. Variations in the pre-operative status of patients coming to primary hip replacement for osteoarthritis in European orthopaedic centres. BMC Musculoskelet Disord 2009;10:19.
21. Cicuttini FM, Baker J, Hart DJ, Spector TD. Association of pain with radiological changes in different compartments and views of the knee joint. Osteoarthritis Cartilage 1996;4:143-7.
22. Hannan MT, Felson DT, Pincus T. Analysis of the discordance between radiographic changes and knee pain in osteoarthritis of the knee. J Rheumatol 2000;27:1513-7.
23. Lethbridge-Cejku M, Scott WW Jr, Reichle R, Ettinger WH, Zonderman A, Costa P, et al. Association of radiographic features of osteoarthritis of the knee with knee pain: data from the Baltimore Longitudinal Study of Aging. Arthritis Care Res 1995;8:182-8.
24. Szebenyi B, Hollander AP, Dieppe P, Quilty B, Duddy J, Clarke S, et al. Associations between pain, function, and radiographic features in osteoarthritis of the knee. Arthritis Rheum 2006;54:230-5.